Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04178941 · ClinicalTrials.gov registry record · NA
Aligning Pulse Oximetry With Guidelines
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 1,898
- Enrollment target
NCT04178941: Completed NA study, sponsored by Children's Hospital of Philadelphia.
NCT04178941 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 1,898 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04178941, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,898 participants
- Enrollment target
Study Summary
The primary objective is to measure the feasibility, acceptability, and appropriateness of audit and feedback with educational outreach as a strategy to align continuous pulse oximetry use in stable bronchiolitis patients with evidence and guideline recommendations.
Primary Outcome
The participant rates the feasibility of the intervention based on this statement: "Data feedback about our use of continuous pulse oximetry in patients with bronchiolitis is easy to implement." Data was only collected from the "STAFF SURVEYED - Intervention (Single Arm)" Arm/Group for this Outcome Measure.
Interventions
- BEHAVIORAL Audit and Feedback
- BEHAVIORAL Educational outreach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,898 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
What the finished NCT04178941 record still lists
NCT04178941 is an interventional study that assigns participants to a tested intervention. Its 1,898 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (35% higher).
The record links to 0 conditions, and to 2 interventions - of which Audit and Feedback is the first listed.
NCT04178941 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04178941 about?
NCT04178941 is a clinical study titled "Aligning Pulse Oximetry With Guidelines". The primary objective is to measure the feasibility, acceptability, and appropriateness of audit and feedback with educational outreach as a strategy to align continuous pulse oximetry use in stable bronchiolitis patients with evidence and guideline recommendations.
What is the current status of trial NCT04178941?
This trial is currently completed. It is a NA study. The enrollment target is 1,898 participants. The study started on 2019-12-02. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT04178941?
The interventions under investigation include: Audit and Feedback (BEHAVIORAL), Educational outreach (BEHAVIORAL).
Who is sponsoring clinical trial NCT04178941?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04178941's enrollment target sits among peer trials
1,898 55th of 2000 higher than 1,946 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- NCT06929806 · 1,900 participants · Phase 3
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
- NCT07228234 · 1,900 participants · NA
Evaluating Mammography Communication Approaches
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI